1 Antihypertensive Market Overview 1.1 Antihypertensive Product Scope 1.2 Antihypertensive Segment by Type 1.2.1 Global Antihypertensive Sales by Type (2020-2026) 1.2.2 Diuretics 1.2.3 Angiotensin receptorblockers (ARBs) 1.2.4 Angiotensin converting enzyme (ACE) inhibitors 1.2.5 Beta blockers 1.2.6 Alpha blockers 1.2.7 Calcium channel blockers 1.2.8 Renin inhibitors 1.2.9 Vasodilators 1.3 Antihypertensive Segment by Application 1.3.1 Global Antihypertensive Sales Comparison by Application (2020-2026) 1.3.2 Hosptial 1.3.3 Clinic 1.3.4 Home 1.4 Antihypertensive Market Estimates and Forecasts (2015-2026) 1.4.1 Global Antihypertensive Sales Growth Rate (2015-2026) 1.4.2 Global Antihypertensive Revenue and Growth Rate (2015-2026) 1.4.3 Global Antihypertensive Price Trends (2015-2026) 2 Antihypertensive Estimate and Forecast by Region 2.1 Global Antihypertensive Market Size by Region: 2015 VS 2020 VS 2026 2.2 Global Antihypertensive Retrospective Market Scenario by Region (2015-2020) 2.2.1 Global Antihypertensive Sales Market Share by Region (2015-2020) 2.2.2 Global Antihypertensive Revenue Market Share by Region (2015-2020) 2.3 Global Antihypertensive Market Estimates and Forecasts by Region (2021-2026) 2.3.1 Global Antihypertensive Sales Estimates and Forecasts by Region (2021-2026) 2.3.2 Global Antihypertensive Revenue Forecast by Region (2021-2026) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Antihypertensive Estimates and Projections (2015-2026) 2.4.2 Europe Antihypertensive Estimates and Projections (2015-2026) 2.4.3 China Antihypertensive Estimates and Projections (2015-2026) 2.4.4 Japan Antihypertensive Estimates and Projections (2015-2026) 2.4.5 Southeast Asia Antihypertensive Estimates and Projections (2015-2026) 2.4.6 India Antihypertensive Estimates and Projections (2015-2026) 3 Global Antihypertensive Competition Landscape by Players 3.1 Global Top Antihypertensive Players by Sales (2015-2020) 3.2 Global Top Antihypertensive Players by Revenue (2015-2020) 3.3 Global Antihypertensive Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihypertensive as of 2019) 3.4 Global Antihypertensive Average Price by Company (2015-2020) 3.5 Manufacturers Antihypertensive Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3.7 Primary Interviews with Key Antihypertensive Players (Opinion Leaders) 4 Global Antihypertensive Market Size by Type 4.1 Global Antihypertensive Historic Market Review by Type (2015-2020) 4.1.1 Global Antihypertensive Sales Market Share by Type (2015-2020) 4.1.2 Global Antihypertensive Revenue Market Share by Type (2015-2020) 4.1.3 Global Antihypertensive Price by Type (2015-2020) 4.2 Global Antihypertensive Market Estimates and Forecasts by Type (2021-2026) 4.2.1 Global Antihypertensive Sales Forecast by Type (2021-2026) 4.2.2 Global Antihypertensive Revenue Forecast by Type (2021-2026) 4.2.3 Global Antihypertensive Price Forecast by Type (2021-2026) 5 Global Antihypertensive Market Size by Application 5.1 Global Antihypertensive Historic Market Review by Application (2015-2020) 5.1.1 Global Antihypertensive Sales Market Share by Application (2015-2020) 5.1.2 Global Antihypertensive Revenue Market Share by Application (2015-2020) 5.1.3 Global Antihypertensive Price by Application (2015-2020) 5.2 Global Antihypertensive Market Estimates and Forecasts by Application (2021-2026) 5.2.1 Global Antihypertensive Sales Forecast by Application (2021-2026) 5.2.2 Global Antihypertensive Revenue Forecast by Application (2021-2026) 5.2.3 Global Antihypertensive Price Forecast by Application (2021-2026) 6 United States Antihypertensive Market Facts & Figures 6.1 United States Antihypertensive Sales Market Share by Company (2015-2020) 6.2 United States Antihypertensive Sales Market Share by Type (2015-2020) 6.3 United States Antihypertensive Sales Market Share by Application (2015-2020) 7 Europe Antihypertensive Market Facts & Figures 7.1 Europe Antihypertensive Sales Market Share by Company (2015-2020) 7.2 Europe Antihypertensive Sales Market Share by Type (2015-2020) 7.3 Europe Antihypertensive Sales Market Share by Application (2015-2020) 8 China Antihypertensive Market Facts & Figures 8.1 China Antihypertensive Sales Market Share by Company (2015-2020) 8.2 China Antihypertensive Sales Market Share by Type (2015-2020) 8.3 China Antihypertensive Sales Market Share by Application (2015-2020) 9 Japan Antihypertensive Market Facts & Figures 9.1 Japan Antihypertensive Sales Market Share by Company (3015-3030) 9.2 Japan Antihypertensive Sales Market Share by Type (2015-2020) 9.3 Japan Antihypertensive Sales Market Share by Application (2015-2020) 10 Southeast Asia Antihypertensive Market Facts & Figures 10.1 Southeast Asia Antihypertensive Sales Market Share by Company (2015-2020) 10.2 Southeast Asia Antihypertensive Sales Market Share by Type (2015-2020) 10.3 Southeast Asia Antihypertensive Sales Market Share by Application (2015-2020) 11 India Antihypertensive Market Facts & Figures 11.1 India Antihypertensive Sales Market Share by Company (2015-2020) 11.2 India Antihypertensive Sales Market Share by Type (2015-2020) 11.3 India Antihypertensive Sales Market Share by Application (2015-2020) 12 Company Profiles and Key Figures in Antihypertensive Business 12.1 Pfizer 12.1.1 Pfizer Corporation Information 12.1.2 Pfizer Business Overview 12.1.3 Pfizer Antihypertensive Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Pfizer Antihypertensive Products Offered 12.1.5 Pfizer Recent Development 12.2 Novartis 12.2.1 Novartis Corporation Information 12.2.2 Novartis Business Overview 12.2.3 Novartis Antihypertensive Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Novartis Antihypertensive Products Offered 12.2.5 Novartis Recent Development 12.3 Sanofi 12.3.1 Sanofi Corporation Information 12.3.2 Sanofi Business Overview 12.3.3 Sanofi Antihypertensive Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Sanofi Antihypertensive Products Offered 12.3.5 Sanofi Recent Development 12.4 Merck 12.4.1 Merck Corporation Information 12.4.2 Merck Business Overview 12.4.3 Merck Antihypertensive Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Merck Antihypertensive Products Offered 12.4.5 Merck Recent Development 12.5 Boehringer Ingelheim 12.5.1 Boehringer Ingelheim Corporation Information 12.5.2 Boehringer Ingelheim Business Overview 12.5.3 Boehringer Ingelheim Antihypertensive Sales, Revenue and Gross Margin (2015-2020) 12.5.4 Boehringer Ingelheim Antihypertensive Products Offered 12.5.5 Boehringer Ingelheim Recent Development 12.6 Lupin 12.6.1 Lupin Corporation Information 12.6.2 Lupin Business Overview 12.6.3 Lupin Antihypertensive Sales, Revenue and Gross Margin (2015-2020) 12.6.4 Lupin Antihypertensive Products Offered 12.6.5 Lupin Recent Development 12.7 Johnson & Johnson 12.7.1 Johnson & Johnson Corporation Information 12.7.2 Johnson & Johnson Business Overview 12.7.3 Johnson & Johnson Antihypertensive Sales, Revenue and Gross Margin (2015-2020) 12.7.4 Johnson & Johnson Antihypertensive Products Offered 12.7.5 Johnson & Johnson Recent Development 12.8 Astra Zeneca 12.8.1 Astra Zeneca Corporation Information 12.8.2 Astra Zeneca Business Overview 12.8.3 Astra Zeneca Antihypertensive Sales, Revenue and Gross Margin (2015-2020) 12.8.4 Astra Zeneca Antihypertensive Products Offered 12.8.5 Astra Zeneca Recent Development 12.9 Daiichi Sankyo 12.9.1 Daiichi Sankyo Corporation Information 12.9.2 Daiichi Sankyo Business Overview 12.9.3 Daiichi Sankyo Antihypertensive Sales, Revenue and Gross Margin (2015-2020) 12.9.4 Daiichi Sankyo Antihypertensive Products Offered 12.9.5 Daiichi Sankyo Recent Development 12.10 Ranbaxy 12.10.1 Ranbaxy Corporation Information 12.10.2 Ranbaxy Business Overview 12.10.3 Ranbaxy Antihypertensive Sales, Revenue and Gross Margin (2015-2020) 12.10.4 Ranbaxy Antihypertensive Products Offered 12.10.5 Ranbaxy Recent Development 13 Antihypertensive Manufacturing Cost Analysis 13.1 Antihypertensive Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Antihypertensive 13.4 Antihypertensive Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Antihypertensive Distributors List 14.3 Antihypertensive Customers 15 Market Dynamics 15.1 Antihypertensive Market Trends 15.2 Antihypertensive Opportunities and Drivers 15.3 Antihypertensive Market Challenges 15.4 Antihypertensive Market Restraints 15.5 Porter's Five Forces Analysis 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Antihypertensive Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million) Table 2. Global Antihypertensive Sales (K Units) Comparison by Application (2020-2026) (US$ Million) Table 3. Global Market Antihypertensive Market Size (US$ Million) by Region:2015 VS 2020 &2026 Table 4. Global Antihypertensive Sales (K Units) by Region (2015-2020) Table 5. Global Antihypertensive Sales Market Share by Region (2015-2020) Table 6. Global Antihypertensive Revenue (US$ Million) Market Share by Region (2015-2020)) Table 7. Global Antihypertensive Revenue Share by Region (2015-2020) Table 8. Global Antihypertensive Sales (K Units) Forecast by Region (2021-2026) Table 9. Global Antihypertensive Sales Market Share Forecast by Region (2021-2026) Table 10. Global Antihypertensive Revenue (US$ Million) Forecast by Region (2021-2026) Table 11. Global Antihypertensive Revenue Share Forecast by Region (2021-2026) Table 12. Global Antihypertensive (K Units) of Key Companies (2015-2020) Table 13. Global Antihypertensive Sales Share by Company (2015-2020) Table 14. Global Antihypertensive Revenue (US$ Million) by Company (2015-2020) Table 15. Global Antihypertensive Revenue Share by Company (2015-2020) Table 16. Global Antihypertensive by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihypertensive as of 2019) Table 17. Global Antihypertensive Average Price (USD/Unit) of Key Company (2015-2020) Table 18. Manufacturers Antihypertensive Manufacturing Sites and Area Served Table 19. Manufacturers Antihypertensive Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Main Points Interviewed from Key Antihypertensive Players Table 22. Global Antihypertensive Sales (K Units) by Type (2015-2020) Table 23. Global Antihypertensive Sales Share by Type (2015-2020) Table 24. Global Antihypertensive Revenue (US$ Million) Market Share by Type (2015-2020) Table 25. Global Antihypertensive Price (K Units) by Type (2015-2020) Table 26. Global Antihypertensive Sales Share by Type (2021-2026) Table 27. Global Antihypertensive Revenue (US$ Million) Market Share by Type (2021-2026) Table 28. Global Antihypertensive Revenue Share by Type (2021-2026) Table 29. Global Antihypertensive Price (K Units) by Type (2021-2026) Table 30. Global Antihypertensive Sales (K Units) by Application (2015-2020) Table 31. Global Antihypertensive Sales Share by Application (2015-2020) Table 32. Global Antihypertensive Revenue (US$ Million) Market Share by Application (2015-2020) Table 33. Global Antihypertensive Price (K Units) by Application (2015-2020) Table 34. Global Antihypertensive Sales (K Units) by Application (2021-2026) Table 35. Global Antihypertensive Sales Share by Application (2021-2026) Table 36. Global Antihypertensive Revenue (US$ Million) Market Share by Application (2021-2026) Table 37. Global Antihypertensive Revenue Share by Application (2021-2026) Table 38. Global Antihypertensive Price (K Units) by Application (2021-2026) Table 39. United States Antihypertensive Sales (K Units) by Company (2015-2020) Table 40. United States Antihypertensive Sales Market Share by Company (2015-2020) Table 41. United States Antihypertensive Sales (K Units) by Type (2015-2020) Table 42. United States Antihypertensive Sales Market Share by Type (2015-2020) Table 43. United States Antihypertensive Sales (K Units) by Application (2015-2020) Table 44. United States Antihypertensive Sales Market Share by Application (2015-2020) Table 45. Europe Antihypertensive Sales (K Units) by Company (2015-2020) Table 46. Europe Antihypertensive Sales Market Share by Company (2015-2020) Table 47. Europe Antihypertensive Sales (K Units) by Type (2015-2020) Table 48. Europe Antihypertensive Sales Market Share by Type (2015-2020) Table 49. Europe Antihypertensive Sales (K Units) by Application (2015-2020) Table 50. Europe Antihypertensive Sales Market Share by Type (2015-2020) Table 51. China Antihypertensive Sales (K Units) by Company (2015-2020) Table 52. China Antihypertensive Sales Market Share by Company (2015-2020) Table 53. China Antihypertensive Sales (K Units) by Type (2015-2020) Table 54. China Antihypertensive Sales Market Share by Type (2015-2020) Table 55. China Antihypertensive Sales (K Units) by Application (2015-2020) Table 56. China Antihypertensive Sales Market Share by Application (2015-2020) Table 57. Japan Antihypertensive Sales (K Units) by Company (2015-2020) Table 58. Japan Antihypertensive Sales Market Share by Company (2015-2020) Table 59. Japan Antihypertensive Sales (K Units) by Type (2015-2020) Table 60. Japan Antihypertensive Sales Market Share by Type (2015-2020) Table 61. Japan Antihypertensive Sales (K Units) by Application (2015-2020) Table 62. Japan Antihypertensive Sales Market Share by Application (2015-2020) Table 63. Southeast Asia Antihypertensive Sales (K Units) by Company (2015-2020) Table 64. Southeast Asia Antihypertensive Sales Market Share by Company (2015-2020) Table 65. Southeast Asia Antihypertensive Sales (K Units) by Type (2015-2020) Table 66. Southeast Asia Antihypertensive Sales Market Share by Type (2015-2020) Table 67. Southeast Asia Antihypertensive Sales (K Units) by Type (2015-2020) Table 68. Southeast Asia Antihypertensive Sales Market Share by Application (2015-2020) Table 69. India Antihypertensive Sales (K Units) by Company (2015-2020) Table 70. India Antihypertensive Sales Market Share by Company (2015-2020) Table 71. India Antihypertensive Sales (K Units) by Type (2015-2020) Table 72. India Antihypertensive Sales Market Share by Type (2015-2020) Table 73. India Antihypertensive Sales (K Units) by Application (2015-2020) Table 74. India Antihypertensive Sales Market Share by Application (2015-2020) Table 75. Pfizer Corporation Information Table 76. Pfizer Description and Business Overview Table 77. Pfizer Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 78. Pfizer Antihypertensive Product Table 79. Pfizer Recent Development Table 80. Novartis Corporation Information Table 81. Novartis Description and Business Overview Table 82. Novartis Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 83. Novartis Antihypertensive Product Table 84. Novartis Recent Development Table 85. Sanofi Corporation Information Table 86. Sanofi Description and Business Overview Table 87. Sanofi Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 88. Sanofi Antihypertensive Product Table 89. Sanofi Recent Development Table 90. Merck Corporation Information Table 91. Merck Description and Business Overview Table 92. Merck Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 93. Merck Antihypertensive Product Table 94. Merck Recent Development Table 95. Boehringer Ingelheim Corporation Information Table 96. Boehringer Ingelheim Description and Business Overview Table 97. Boehringer Ingelheim Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 98. Boehringer Ingelheim Antihypertensive Product Table 99. Boehringer Ingelheim Recent Development Table 100. Lupin Corporation Information Table 101. Lupin Description and Business Overview Table 102. Lupin Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 103. Lupin Antihypertensive Product Table 104. Lupin Recent Development Table 105. Johnson & Johnson Corporation Information Table 106. Johnson & Johnson Description and Business Overview Table 107. Johnson & Johnson Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 108. Johnson & Johnson Antihypertensive Product Table 109. Johnson & Johnson Recent Development Table 110. Astra Zeneca Corporation Information Table 111. Astra Zeneca Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 112. Astra Zeneca Description and Business Overview Table 113. Astra Zeneca Antihypertensive Product Table 114. Astra Zeneca Recent Development Table 115. Daiichi Sankyo Corporation Information Table 116. Daiichi Sankyo Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 117. Daiichi Sankyo Description and Business Overview Table 118. Daiichi Sankyo Antihypertensive Product Table 119. Daiichi Sankyo Recent Development Table 120. Ranbaxy Corporation Information Table 121. Ranbaxy Description and Business Overview Table 122. Ranbaxy Antihypertensive Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 123. Ranbaxy Antihypertensive Product Table 124. Ranbaxy Recent Development Table 125. Production Base and Market Concentration Rate of Raw Material Table 126. Key Suppliers of Raw Materials Table 127. Antihypertensive Distributors List Table 128. Antihypertensive Customers List Table 129. Antihypertensive Market Key Trends Table 130. Antihypertensive Key Opportunities and Drivers Table 131. Antihypertensive Market Challenges Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Antihypertensive Product Picture Figure 2. Global Antihypertensive Sales Market Share by Type in 2020 & 2026 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Antihypertensive Market Share by Application in 2020 & 2026 Figure 6. Hosptial Examples Figure 7. Clinic Examples Figure 8. Home Examples Figure 9. Global Antihypertensive Sales (K Units) Growth Rate (2015-2026) Figure 10. Global Antihypertensive Revenue (US$ Million) Growth Rate (2015-2026) Figure 11. Global Antihypertensive Price Trends Growth Rate (2015-2026) (USD/Unit) Figure 12. Global Antihypertensive Revenue Market Share by Region: 2015 VS 2020 Figure 13. Global Antihypertensive Revenue Market Share by Region: 2021 VS 2026 Figure 14. United States Antihypertensive Revenue (Million USD) Growth Rate (2015-2026) Figure 15. United States Antihypertensive Sales (K Units) Growth Rate (2015-2026) Figure 16. Europe Antihypertensive Revenue (Million USD) Growth Rate (2015-2026) Figure 17. Europe Antihypertensive Sales (Million USD) Growth Rate (2015-2026) Figure 18. China Antihypertensive Revenue (Million USD) Growth Rate (2015-2026) Figure 19. China Antihypertensive Sales (Million USD) and Growth Rate (2015-2026) Figure 20. Japan Antihypertensive Revenue (Million USD) Growth Rate (2015-2026) Figure 21. Japan Antihypertensive Sales (Million USD) Growth Rate (2015-2026) Figure 22. Southeast Asia Antihypertensive Revenue (Million USD) Growth Rate (2015-2026) Figure 23. Southeast Asia Antihypertensive Sales (Million USD) Growth Rate (2015-2026) Figure 24. India Antihypertensive Revenue (Million USD) Growth Rate (2015-2026) Figure 25. India Antihypertensive Sales (Million USD) Growth Rate (2015-2026) Figure 26. Global 5 Largest Antihypertensive Players Market Share by Revenue in Antihypertensive 2015 & 2019 Figure 27. Antihypertensive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 28. Global Antihypertensive Revenue Share by Type (2015-2020) Figure 29. Global Antihypertensive Revenue Growth Rate by Type in 2015 & 2019 Figure 30. Global Antihypertensive Revenue Share by Application (2015-2020) Figure 31. Global Antihypertensive Revenue Growth Rate by Application in 2015 & 2019 Figure 32. United States Antihypertensive Sales Market Share by Type in 2019 Figure 33. United States Antihypertensive Sales Market Share by Type in 2019 Figure 34. Europe Antihypertensive Sales Market Share by Company in 2019 Figure 35. Europe Antihypertensive Sales Market Share by Type in 2019 Figure 36. Europe Antihypertensive Sales Market Share by Application in 2019 Figure 37. China Antihypertensive Sales Market Share by Company in 2019 Figure 38. China Antihypertensive Sales Market Share by Type in 2019 Figure 39. China Antihypertensive Sales Market Share by Application in 2019 Figure 40. Japan Antihypertensive Sales Market Share by Company in 2019 Figure 41. Japan Antihypertensive Sales Market Share by Type in 2019 Figure 42. Japan Antihypertensive Sales Market Share by Application in 2019 Figure 43. Southeast Asia Antihypertensive Sales Market Share by Company in 2019 Figure 44. Southeast Asia Antihypertensive Sales Market Share by Type in 2019 Figure 45. Southeast Asia Antihypertensive Sales Market Share by Application in 2019 Figure 46. India Antihypertensive Sales Market Share by Company in 2019 Figure 47. India Antihypertensive Sales Market Share by Type in 2019 Figure 48. India Antihypertensive Sales Market Share by Application in 2019 Figure 49. Key Raw Materials Price Trend Figure 50. Manufacturing Cost Structure of Antihypertensive Figure 51. Manufacturing Process Analysis of Antihypertensive Figure 52. Antihypertensive Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Porter's Five Forces Analysis Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Pfizer Novartis Sanofi Merck Boehringer Ingelheim Lupin Johnson & Johnson Astra Zeneca Daiichi Sankyo Ranbaxy